Clinical significance of geriatric nutritional risk index in esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy
- 8 April 2024
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (6) , 108323
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta-AnalysisThe Oncologist, 2021
- Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction CancerNew England Journal of Medicine, 2021
- Association of relative dose intensity with BMI and pathologic complete response in patients treated with neoadjuvant chemotherapy for breast cancerBreast Cancer Research and Treatment, 2020
- Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphomaAnnals of Hematology, 2020
- Prediction of postoperative complications and survival after laparoscopic gastrectomy using preoperative Geriatric Nutritional Risk Index in elderly gastric cancer patientsSurgical Endoscopy, 2020
- Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trialThe Lancet Oncology, 2019
- The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancerEsophagus, 2018
- Barriers to cancer nutrition therapy: excess catabolism of muscle and adipose tissues induced by tumour products and chemotherapyProceedings of the Nutrition Society, 2018
- Preoperative Chemoradiotherapy for Esophageal or Junctional CancerNew England Journal of Medicine, 2012
- Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiationCancer, 2005